ViiV presses go on FDA filing for first-in-class HIV drug fostemsavir

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Dec 6, 2019 at 10:12 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,057
    Likes Received:
    3
    via ViiV Healthcare has fulfilled its pledge of submitting its new HIV drug fostemsavir for approval before year end, filing a dossier with the FDA.

    article source